38
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Can biowarfare agents be defeated with light?

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Biological warfare and bioterrorism is an unpleasant fact of 21st century life. Highly infectious and profoundly virulent diseases may be caused in combat personnel or in civilian populations by the appropriate dissemination of viruses, bacteria, spores, fungi, or toxins. Dissemination may be airborne, waterborne, or by contamination of food or surfaces. Countermeasures may be directed toward destroying or neutralizing the agents outside the body before infection has taken place, by destroying the agents once they have entered the body before the disease has fully developed, or by immunizing susceptible populations against the effects. A range of light-based technologies may have a role to play in biodefense countermeasures. Germicidal UV (UVC) is exceptionally active in destroying a wide range of viruses and microbial cells, and recent data suggests that UVC has high selectivity over host mammalian cells and tissues. Two UVA mediated approaches may also have roles to play; one where UVA is combined with titanium dioxide nanoparticles in a process called photocatalysis, and a second where UVA is combined with psoralens (PUVA) to produce “killed but metabolically active” microbial cells that may be particularly suitable for vaccines. Many microbial cells are surprisingly sensitive to blue light alone, and blue light can effectively destroy bacteria, fungi, and Bacillus spores and can treat wound infections. The combination of photosensitizing dyes such as porphyrins or phenothiaziniums and red light is called photodynamic therapy (PDT) or photoinactivation, and this approach cannot only kill bacteria, spores, and fungi, but also inactivate viruses and toxins. Many reports have highlighted the ability of PDT to treat infections and stimulate the host immune system. Finally pulsed (femtosecond) high power lasers have been used to inactivate pathogens with some degree of selectivity. We have pointed to some of the ways light-based technology may be used to defeat biological warfare in the future.

          Related collections

          Most cited references215

          • Record: found
          • Abstract: found
          • Article: not found

          Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

          As the epidemiology of infections with methicillin-resistant Staphylococcus aureus (MRSA) changes, accurate information on the scope and magnitude of MRSA infections in the US population is needed. To describe the incidence and distribution of invasive MRSA disease in 9 US communities and to estimate the burden of invasive MRSA infections in the United States in 2005. Active, population-based surveillance for invasive MRSA in 9 sites participating in the Active Bacterial Core surveillance (ABCs)/Emerging Infections Program Network from July 2004 through December 2005. Reports of MRSA were investigated and classified as either health care-associated (either hospital-onset or community-onset) or community-associated (patients without established health care risk factors for MRSA). Incidence rates and estimated number of invasive MRSA infections and in-hospital deaths among patients with MRSA in the United States in 2005; interval estimates of incidence excluding 1 site that appeared to be an outlier with the highest incidence; molecular characterization of infecting strains. There were 8987 observed cases of invasive MRSA reported during the surveillance period. Most MRSA infections were health care-associated: 5250 (58.4%) were community-onset infections, 2389 (26.6%) were hospital-onset infections; 1234 (13.7%) were community-associated infections, and 114 (1.3%) could not be classified. In 2005, the standardized incidence rate of invasive MRSA was 31.8 per 100,000 (interval estimate, 24.4-35.2). Incidence rates were highest among persons 65 years and older (127.7 per 100,000; interval estimate, 92.6-156.9), blacks (66.5 per 100,000; interval estimate, 43.5-63.1), and males (37.5 per 100,000; interval estimate, 26.8-39.5). There were 1598 in-hospital deaths among patients with MRSA infection during the surveillance period. In 2005, the standardized mortality rate was 6.3 per 100,000 (interval estimate, 3.3-7.5). Molecular testing identified strains historically associated with community-associated disease outbreaks recovered from cultures in both hospital-onset and community-onset health care-associated infections in all surveillance areas. Invasive MRSA infection affects certain populations disproportionately. It is a major public health problem primarily related to health care but no longer confined to intensive care units, acute care hospitals, or any health care institution.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            A review on the visible light active titanium dioxide photocatalysts for environmental applications

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              TiO2Photocatalysis: A Historical Overview and Future Prospects

                Bookmark

                Author and article information

                Journal
                Virulence
                Virulence
                VIRU
                Virulence
                Landes Bioscience
                2150-5594
                2150-5608
                15 November 2013
                25 September 2013
                25 September 2013
                : 4
                : 8
                : 796-825
                Affiliations
                [1 ]Wellman Center for Photomedicine; Massachusetts General Hospital; Boston MA USA
                [2 ]Harvard Medical School; Department of Dermatology; Boston, MA USA
                [3 ]Laboratory of Electro-thermo-phototherapy; Department of Physical Therapy; Federal University of São Carlos; São Paulo, Brazil
                [4 ]Post-Graduation Program in Biotechnology; Federal University of São Carlos; São Paulo, Brazil
                [5 ]Optics Group; Physics Institute of Sao Carlos; University of São Paulo; São Carlos, Brazil
                [6 ]Laboratory of Radiation Dosimetry and Medical Physics; Institute of Physics, São Paulo University, São Paulo, Brazil
                [7 ]Department of Dermatology; Southwest Hospital; Third Military Medical University; Chongqing, PR China
                [8 ]School of Chemistry; University of Wollongong; Wollongong, NSW Australia
                [9 ]Raja Ramanna Centre for Advanced Technology; Indore, India
                [10 ]Harvard-MIT Division of Health Sciences and Technology; Cambridge, MA USA
                Author notes
                [* ]Correspondence to: Michael R Hamblin, Email: hamblin@ 123456helix.mgh.harvard.edu
                Article
                2012VIRULENCE0118R 26475
                10.4161/viru.26475
                3925713
                24067444
                152d6f24-6faf-4568-80a7-05c64ec8c8a6
                Copyright © 2013 Landes Bioscience

                This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.

                History
                : 03 June 2013
                : 10 September 2013
                : 12 September 2013
                Categories
                Special Focus Review

                Infectious disease & Microbiology
                uv dosimeters,bioterrorism,biowarfare,blue light inactivation,germicidal ultraviolet,microbial cells,photo inactivation,photocatalysis,photocatalytic inactivation,photodynamic therapy,psorales,titanium dioxide,ultraviolet light

                Comments

                Comment on this article